文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

动脉粥样硬化病理学中的表观遗传调控:一种新视角。

Epigenetic Regulation in Pathology of Atherosclerosis: A Novel Perspective.

作者信息

Tang Haishuang, Zeng Zhangwei, Shang Chenghao, Li Qiang, Liu Jianmin

机构信息

Department of Neurosurgery, Changhai Hospital, Naval Military Medical University, Shanghai, China.

出版信息

Front Genet. 2021 Dec 15;12:810689. doi: 10.3389/fgene.2021.810689. eCollection 2021.


DOI:10.3389/fgene.2021.810689
PMID:34976029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8714670/
Abstract

Atherosclerosis, characterized by atherosclerotic plaques, is a complex pathological process that involves different cell types and can be seen as a chronic inflammatory disease. In the advanced stage, the ruptured atherosclerotic plaque can induce deadly accidents including ischemic stroke and myocardial infarction. Epigenetics regulation, including DNA methylation, histone modification, and non-coding RNA modification. maintains cellular identity affecting the cellular transcriptome. The epigenetic modification process, mediating by epigenetic enzymes, is dynamic under various stimuli, which can be reversely altered. Recently, numerous studies have evidenced the close relationship between atherosclerosis and epigenetic regulations in atherosclerosis, providing us with a novel perspective in researching mechanisms and finding novel therapeutic targets of this serious disease. Here, we critically review the recent discoveries between epigenetic regulation mechanisms in atherosclerosis.

摘要

动脉粥样硬化以动脉粥样硬化斑块为特征,是一个复杂的病理过程,涉及不同细胞类型,可被视为一种慢性炎症性疾病。在晚期,破裂的动脉粥样硬化斑块可引发致命事故,包括缺血性中风和心肌梗死。表观遗传学调控,包括DNA甲基化、组蛋白修饰和非编码RNA修饰,维持细胞特性并影响细胞转录组。由表观遗传酶介导的表观遗传修饰过程在各种刺激下是动态的,可发生可逆改变。最近,大量研究证明了动脉粥样硬化与表观遗传学调控之间的密切关系,为我们研究这种严重疾病的发病机制和寻找新的治疗靶点提供了新的视角。在此,我们批判性地综述了动脉粥样硬化表观遗传调控机制的最新发现。

相似文献

[1]
Epigenetic Regulation in Pathology of Atherosclerosis: A Novel Perspective.

Front Genet. 2021-12-15

[2]
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Pharmacol Ther. 2018-11-13

[3]
Cell-specific epigenetic changes in atherosclerosis.

Clin Sci (Lond). 2021-5-14

[4]
Epigenetic Regulation in Atherosclerosis.

Discov Med. 2021

[5]
DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy.

Cell Commun Signal. 2023-11-29

[6]
Minor Changes for a Major Impact: A Review of Epigenetic Modifications in Cell-Based Therapies for Stroke.

Int J Mol Sci. 2022-10-28

[7]
Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis.

Diabetes Metab Syndr Obes. 2024-4-29

[8]
Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods.

Trends Mol Med. 2017-3-11

[9]
Epigenetic Regulations of Microglia/Macrophage Polarization in Ischemic Stroke.

Front Mol Neurosci. 2021-10-11

[10]
Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.

Life Sci. 2014-10-31

引用本文的文献

[1]
Plant polysaccharides influence tumor development based on epigenetics: a review.

Front Pharmacol. 2025-5-6

[2]
Metaboloepigenetics: Role in the Regulation of Flow-Mediated Endothelial (Dys)Function and Atherosclerosis.

Cells. 2025-3-5

[3]
High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.

Nutrients. 2024-12-31

[4]
Deciphering Structural Dynamics of Atherosclerosis Proteins: Insights from Phytochemicals that Interceded Functional and Structural Changes in Targeted Atherosclerotic Proteins.

ACS Omega. 2024-11-23

[5]
[New treatment for HDL cholesterol with Trichosanthin A and metformin in prediabetes: controlled clinical trial].

Rev Med Inst Mex Seguro Soc. 2024-3-4

[6]
Circulating microRNAs in Carotid Atherosclerosis: Complex Interplay and Possible Associations with Atherothrombotic Stroke.

Int J Mol Sci. 2024-9-18

[7]
Effects of vitamin D signaling in cardiovascular disease: centrality of macrophage polarization.

Front Cardiovasc Med. 2024-6-25

[8]
Targeting Oncostatin M Receptor to Attenuate Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine.

Cardiol Cardiovasc Med. 2024

[9]
Epigenetics and environmental health.

Front Med. 2024-8

[10]
Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis.

Diabetes Metab Syndr Obes. 2024-4-29

本文引用的文献

[1]
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis the miR-146a-5p/ANGPTL4 Pathway.

Front Cardiovasc Med. 2021-11-8

[2]
Epigenetic Signaling of Cancer Stem Cells During Inflammation.

Front Cell Dev Biol. 2021-10-15

[3]
FAK Activation Promotes SMC Dedifferentiation via Increased DNA Methylation in Contractile Genes.

Circ Res. 2021-12-3

[4]
Therapeutic perspectives of extracellular vesicles and extracellular microRNAs in atherosclerosis.

Curr Top Membr. 2021

[5]
Lipid Oxidation Products on Inflammation-Mediated Hypertension and Atherosclerosis: A Mini Review.

Front Nutr. 2021-9-30

[6]
LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway.

Nutr Metab Cardiovasc Dis. 2021-11-29

[7]
The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis.

Front Genet. 2021-9-16

[8]
Epigenetics Modifications in Large-Artery Atherosclerosis: A Systematic Review.

J Stroke Cerebrovasc Dis. 2021-12

[9]
Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis.

Biomedicines. 2021-9-14

[10]
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases.

Front Cardiovasc Med. 2021-9-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索